Read a new publication from Oncowitan and #Polygon Therapeutic: The review discusses the key role of T lymphocytes expressing the CD8 coreceptor (CTL) in diverse cardiovascular diseases and their targeting with drugs, notably anti-CD8 monoclonal antibodies.
Targeting CD8+ T cells in cardiovascular diseases – current options and therapeutic perspectives, Cardiovascular Researc (2025)
